Literature DB >> 7572272

Regulation and function of central nervous system chemokines.

A R Glabinski1, M Tani, S Aras, M H Stoler, V K Tuohy, R M Ransohoff.   

Abstract

In this paper, we discuss the potential involvement of a new family of cytokines, termed chemokines, in CNS inflammatory pathology. Chemokines are a family of proinflammatory cytokines which are able to stimulate target-cell-specific directional migration of leukocytes. Because of this feature, chemokines may be potent mediators of inflammatory processes. We have previously reported observations indicating that chemokines may be involved in the process of lesion formation during autoimmune inflammation within CNS, and, in particular, are likely participants in the process of influx of inflammatory cells into the CNS parenchyma. We observed also that mechanical injury of brain and subsequent post-traumatic inflammation may in part be mediated by chemokines. Chemokines undoubtedly co-operate with cell-associated adhesion molecules during recruitment of leukocytes from blood to CNS. The sequential expression of soluble and membrane-bound signals for leukocyte migration is an intricate process that can be interrupted by a variety of strategies. Our data suggest that chemokines may represent a promising target for future therapy of inflammatory conditions, including CNS inflammation resulting from varied insults.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572272     DOI: 10.1016/0736-5748(95)00017-b

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  20 in total

1.  Murine astrocytes express a functional chemokine receptor.

Authors:  S Tanabe; M Heesen; M A Berman; M B Fischer; I Yoshizawa; Y Luo; M E Dorf
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

2.  Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis.

Authors:  A R Glabinski; M Tani; R M Strieter; V K Tuohy; R M Ransohoff
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 3.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 4.  Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

Authors:  Changjun Yang; Kimberly E Hawkins; Sylvain Doré; Eduardo Candelario-Jalil
Journal:  Am J Physiol Cell Physiol       Date:  2018-10-31       Impact factor: 4.249

Review 5.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 6.  Inflammation in traumatic brain injury: role of cytokines and chemokines.

Authors:  R S Ghirnikar; Y L Lee; L F Eng
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

7.  In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis.

Authors:  M Tani; A R Glabinski; V K Tuohy; M H Stoler; M L Estes; R M Ransohoff
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

8.  Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile.

Authors:  B I Restrepo; J I Alvarez; J A Castaño; L F Arias; M Restrepo; J Trujillo; C H Colegial; J M Teale
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

9.  CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response.

Authors:  Astrid E Cardona; Paula A Gonzalez; Judy M Teale
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 10.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.